data_2aj1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2aj1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.687 -0.116 . . . . 10.0 110.687 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 1.333 ' CA ' ' HA ' ' A' ' 2' ' ' ALA 0.456 . . 163.78 68.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.832 1.653 . . . . 10.0 106.57 -173.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' OE2' ' N ' ' A' ' 1' ' ' MET . 7.7 mm-40 -74.83 84.05 2.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.614 0.721 . . . . 10.0 110.662 -162.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -89.57 141.27 28.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.013 0.925 . . . . 10.0 108.977 158.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.1 m -152.2 150.86 30.3 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -129.33 138.09 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 124.39 1.056 . . . . 10.0 111.555 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -123.13 150.34 43.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.37 1.468 . . . . 10.0 107.394 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -85.58 142.34 29.19 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.364 0.984 . . . . 10.0 109.078 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -122.01 147.39 26.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -148.89 149.24 30.92 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.118 0.417 . . . . 10.0 111.651 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.4 -62.54 0.62 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.882 1.706 . . . . 10.0 112.15 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -77.52 176.94 8.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 -171.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.1 t -168.21 69.11 0.08 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.367 1.067 . . . . 10.0 109.284 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.2 t -150.58 123.91 8.94 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.417 0.553 . . . . 10.0 112.334 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 m -53.07 -43.67 66.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.104 1.362 . . . . 10.0 111.841 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -57.21 -43.81 83.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.692 -0.63 . . . . 10.0 109.846 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -67.27 -42.23 84.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.054 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.2 -51.15 46.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.346 0.521 . . . . 10.0 110.788 171.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.86 63.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.744 0.783 . . . . 10.0 109.753 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -54.67 -39.65 68.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.578 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CD2' ' CZ ' ' A' ' 38' ' ' PHE . 5.6 t80 -67.79 -56.11 10.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.157 -0.34 . . . . 10.0 110.965 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.62 -41.35 73.38 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.705 0.684 . . . . 10.0 110.267 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.46 -52.22 66.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.163 -0.446 . . . . 10.0 110.105 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -47.56 -50.21 24.4 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.1 t -59.92 -52.27 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 117.563 0.165 . . . . 10.0 110.836 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -52.74 -37.82 59.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.076 0.95 . . . . 10.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.67 -3.92 27.98 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.6 mt -84.27 138.49 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.985 1.266 . . . . 10.0 107.881 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -81.56 -21.36 38.51 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.287 1.218 . . . . 10.0 114.287 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -24.98 66.21 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.203 0.906 . . . . 10.0 112.947 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.64 156.97 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 121.549 -0.971 . . . . 10.0 108.786 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -109.14 -55.07 2.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.933 1.293 . . . . 10.0 108.431 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.4 161.66 28.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.01 0.433 . . . . 10.0 111.193 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.54 142.92 20.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.8 mt -133.58 106.15 8.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.41 -1.33 . . . . 10.0 107.41 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.28 113.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.138 0.575 . . . . 10.0 109.793 -173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -101.65 72.52 1.38 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 21' ' ' PHE . 5.9 m-30 -79.91 155.91 27.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.28 -0.873 . . . . 10.0 109.632 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.71 -62.09 0.65 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.496 -1.842 . . . . 10.0 108.496 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.27 55.22 0.06 Allowed 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.091 0.957 . . . . 10.0 108.515 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -155.84 -112.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.37 165.72 35.02 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -151.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.16 112.27 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.571 1.548 . . . . 10.0 107.637 -172.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 m -90.68 134.46 34.39 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 t -115.57 145.22 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.158 -2.164 . . . . 10.0 105.158 170.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.7 m -144.65 125.99 14.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.41 -100.02 0.18 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.679 -2.568 . . . . 10.0 106.679 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -155.69 54.68 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.279 1.432 . . . . 10.0 108.355 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.09 169.86 16.93 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.05 0.94 . . . . 10.0 110.073 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -127.65 160.39 31.77 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.639 1.576 . . . . 10.0 109.279 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.2 tp -53.49 -35.91 26.43 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 117.732 -1.128 . . . . 10.0 112.065 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -32.36 -49.73 0.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.143 1.377 . . . . 10.0 113.81 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.23 -42.19 76.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.617 0.722 . . . . 10.0 112.183 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.54 -47.54 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.861 1.664 . . . . 10.0 110.003 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -51.72 -54.7 25.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.729 2.812 . . . . 10.0 108.892 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -52.43 -53.21 48.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.561 0.344 . . . . 10.0 110.24 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.23 37.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.256 0.623 . . . . 10.0 111.376 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.99 49.68 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.094 0.854 . . . . 10.0 112.842 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.68 -24.15 3.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.537 1.168 . . . . 10.0 111.8 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -54.03 -33.31 56.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 10.0 113.15 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.59 -1.58 8.5 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.936 0.894 . . . . 10.0 113.05 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 65.28 47.13 2.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 10.0 110.129 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.52 151.38 46.08 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 119.628 -0.829 . . . . 10.0 109.741 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 125.75 52.35 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 168.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.0 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.0 mt -107.05 130.49 22.78 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -61.92 114.76 2.43 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.189 1.259 . . . . 10.0 109.081 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.04 60.55 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.948 1.699 . . . . 10.0 109.113 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -71.19 105.31 3.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -52.35 138.57 26.54 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.451 1.9 . . . . 10.0 111.444 -179.647 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.573 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.687 -0.116 . . . . 10.0 110.687 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 1' ' ' MET 0.456 . . 163.78 68.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.832 1.653 . . . . 10.0 106.57 -173.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.83 84.05 2.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.614 0.721 . . . . 10.0 110.662 -162.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -89.57 141.27 28.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.013 0.925 . . . . 10.0 108.977 158.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.1 m -152.2 150.86 30.3 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -129.33 138.09 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 124.39 1.056 . . . . 10.0 111.555 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -123.13 150.34 43.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.37 1.468 . . . . 10.0 107.394 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -85.58 142.34 29.19 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.364 0.984 . . . . 10.0 109.078 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' A' ' 38' ' ' PHE . 1.5 p -122.01 147.39 26.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 174.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -148.89 149.24 30.92 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.118 0.417 . . . . 10.0 111.651 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.4 -62.54 0.62 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.882 1.706 . . . . 10.0 112.15 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' CE2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -77.52 176.94 8.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 -171.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.1 t -168.21 69.11 0.08 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.367 1.067 . . . . 10.0 109.284 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.2 t -150.58 123.91 8.94 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.417 0.553 . . . . 10.0 112.334 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 m -53.07 -43.67 66.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.104 1.362 . . . . 10.0 111.841 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -57.21 -43.81 83.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.692 -0.63 . . . . 10.0 109.846 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -67.27 -42.23 84.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.054 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.2 -51.15 46.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.346 0.521 . . . . 10.0 110.788 171.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.86 63.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.744 0.783 . . . . 10.0 109.753 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -54.67 -39.65 68.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.578 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.558 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 5.6 t80 -67.79 -56.11 10.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.157 -0.34 . . . . 10.0 110.965 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.62 -41.35 73.38 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.705 0.684 . . . . 10.0 110.267 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.46 -52.22 66.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.163 -0.446 . . . . 10.0 110.105 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.56 -50.21 24.4 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 54' ' ' VAL . 57.1 t -59.92 -52.27 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 117.563 0.165 . . . . 10.0 110.836 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -52.74 -37.82 59.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.076 0.95 . . . . 10.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.67 -3.92 27.98 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.6 mt -84.27 138.49 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.985 1.266 . . . . 10.0 107.881 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -81.56 -21.36 38.51 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.287 1.218 . . . . 10.0 114.287 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -24.98 66.21 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.203 0.906 . . . . 10.0 112.947 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.64 156.97 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 121.549 -0.971 . . . . 10.0 108.786 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -109.14 -55.07 2.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.933 1.293 . . . . 10.0 108.431 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.4 161.66 28.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.01 0.433 . . . . 10.0 111.193 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.54 142.92 20.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.8 mt -133.58 106.15 8.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.41 -1.33 . . . . 10.0 107.41 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.28 113.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.138 0.575 . . . . 10.0 109.793 -173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -101.65 72.52 1.38 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' CE2' HD21 ' A' ' 12' ' ' LEU . 5.9 m-30 -79.91 155.91 27.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.28 -0.873 . . . . 10.0 109.632 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.71 -62.09 0.65 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.496 -1.842 . . . . 10.0 108.496 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.27 55.22 0.06 Allowed 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.091 0.957 . . . . 10.0 108.515 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -155.84 -112.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.37 165.72 35.02 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -151.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.16 112.27 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.571 1.548 . . . . 10.0 107.637 -172.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 m -90.68 134.46 34.39 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 t -115.57 145.22 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.158 -2.164 . . . . 10.0 105.158 170.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.7 m -144.65 125.99 14.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.41 -100.02 0.18 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.679 -2.568 . . . . 10.0 106.679 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -155.69 54.68 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.279 1.432 . . . . 10.0 108.355 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.09 169.86 16.93 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.05 0.94 . . . . 10.0 110.073 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -127.65 160.39 31.77 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.639 1.576 . . . . 10.0 109.279 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.2 tp -53.49 -35.91 26.43 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 117.732 -1.128 . . . . 10.0 112.065 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -32.36 -49.73 0.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.143 1.377 . . . . 10.0 113.81 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.23 -42.19 76.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.617 0.722 . . . . 10.0 112.183 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 61.8 t -61.54 -47.54 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.861 1.664 . . . . 10.0 110.003 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -51.72 -54.7 25.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.729 2.812 . . . . 10.0 108.892 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -52.43 -53.21 48.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.561 0.344 . . . . 10.0 110.24 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.75 -43.23 37.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.256 0.623 . . . . 10.0 111.376 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.99 49.68 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.094 0.854 . . . . 10.0 112.842 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.68 -24.15 3.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.537 1.168 . . . . 10.0 111.8 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -54.03 -33.31 56.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 10.0 113.15 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.59 -1.58 8.5 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.936 0.894 . . . . 10.0 113.05 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 65.28 47.13 2.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 10.0 110.129 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.52 151.38 46.08 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 119.628 -0.829 . . . . 10.0 109.741 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 125.75 52.35 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 168.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.0 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.0 mt -107.05 130.49 22.78 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -61.92 114.76 2.43 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.189 1.259 . . . . 10.0 109.081 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.04 60.55 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.948 1.699 . . . . 10.0 109.113 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -71.19 105.31 3.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -52.35 138.57 26.54 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.451 1.9 . . . . 10.0 111.444 -179.647 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.573 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 110.687 -0.116 . . . . 10.0 110.687 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 1' ' ' MET 0.456 . . 163.78 68.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.832 1.653 . . . . 10.0 106.57 -173.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.83 84.05 2.17 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.614 0.721 . . . . 10.0 110.662 -162.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -89.57 141.27 28.74 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.013 0.925 . . . . 10.0 108.977 158.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.1 m -152.2 150.86 30.3 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -129.33 138.09 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 O-C-N 124.39 1.056 . . . . 10.0 111.555 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -123.13 150.34 43.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.37 1.468 . . . . 10.0 107.394 -173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -85.58 142.34 29.19 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.364 0.984 . . . . 10.0 109.078 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' A' ' 38' ' ' PHE . 1.5 p -122.01 147.39 26.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 174.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -148.89 149.24 30.92 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.118 0.417 . . . . 10.0 111.651 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.4 -62.54 0.62 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.882 1.706 . . . . 10.0 112.15 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' CE2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -77.52 176.94 8.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.86 0.689 . . . . 10.0 112.86 -171.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.1 t -168.21 69.11 0.08 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.367 1.067 . . . . 10.0 109.284 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.2 t -150.58 123.91 8.94 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.417 0.553 . . . . 10.0 112.334 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 m -53.07 -43.67 66.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.104 1.362 . . . . 10.0 111.841 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -57.21 -43.81 83.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.692 -0.63 . . . . 10.0 109.846 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -67.27 -42.23 84.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.054 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.2 -51.15 46.44 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.346 0.521 . . . . 10.0 110.788 171.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.86 63.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.744 0.783 . . . . 10.0 109.753 -176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -54.67 -39.65 68.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.578 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.558 ' CZ ' HG12 ' A' ' 54' ' ' VAL . 5.6 t80 -67.79 -56.11 10.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 122.157 -0.34 . . . . 10.0 110.965 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.62 -41.35 73.38 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.705 0.684 . . . . 10.0 110.267 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -60.46 -52.22 66.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.163 -0.446 . . . . 10.0 110.105 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.826 HD22 ' HB1' ' A' ' 57' ' ' ALA . 5.0 m-20 -47.56 -50.21 24.4 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 54' ' ' VAL . 57.1 t -59.92 -52.27 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 117.563 0.165 . . . . 10.0 110.836 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -52.74 -37.82 59.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.076 0.95 . . . . 10.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.67 -3.92 27.98 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.6 mt -84.27 138.49 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.985 1.266 . . . . 10.0 107.881 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -81.56 -21.36 38.51 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.287 1.218 . . . . 10.0 114.287 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.62 -24.98 66.21 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.203 0.906 . . . . 10.0 112.947 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.64 156.97 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 O-C-N 121.549 -0.971 . . . . 10.0 108.786 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -109.14 -55.07 2.46 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.933 1.293 . . . . 10.0 108.431 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.4 161.66 28.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.01 0.433 . . . . 10.0 111.193 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -154.54 142.92 20.54 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 172.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.8 mt -133.58 106.15 8.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.41 -1.33 . . . . 10.0 107.41 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.28 113.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.138 0.575 . . . . 10.0 109.793 -173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -101.65 72.52 1.38 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' CE2' HD21 ' A' ' 12' ' ' LEU . 5.9 m-30 -79.91 155.91 27.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.28 -0.873 . . . . 10.0 109.632 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.71 -62.09 0.65 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.496 -1.842 . . . . 10.0 108.496 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.27 55.22 0.06 Allowed 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.091 0.957 . . . . 10.0 108.515 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -155.84 -112.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -157.37 165.72 35.02 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -151.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.16 112.27 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.571 1.548 . . . . 10.0 107.637 -172.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.2 m -90.68 134.46 34.39 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 t -115.57 145.22 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.158 -2.164 . . . . 10.0 105.158 170.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.7 m -144.65 125.99 14.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.41 -100.02 0.18 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.679 -2.568 . . . . 10.0 106.679 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -155.69 54.68 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.279 1.432 . . . . 10.0 108.355 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.09 169.86 16.93 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.05 0.94 . . . . 10.0 110.073 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -127.65 160.39 31.77 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.639 1.576 . . . . 10.0 109.279 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.2 tp -53.49 -35.91 26.43 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 117.732 -1.128 . . . . 10.0 112.065 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -32.36 -49.73 0.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.143 1.377 . . . . 10.0 113.81 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -69.23 -42.19 76.01 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.617 0.722 . . . . 10.0 112.183 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG12 ' CZ ' ' A' ' 21' ' ' PHE . 61.8 t -61.54 -47.54 92.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.861 1.664 . . . . 10.0 110.003 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -51.72 -54.7 25.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.729 2.812 . . . . 10.0 108.892 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -52.43 -53.21 48.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.561 0.344 . . . . 10.0 110.24 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 24' ' ' ASN . . . -48.75 -43.23 37.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.256 0.623 . . . . 10.0 111.376 175.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.99 49.68 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.094 0.854 . . . . 10.0 112.842 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.68 -24.15 3.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.537 1.168 . . . . 10.0 111.8 170.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -54.03 -33.31 56.92 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.362 0.983 . . . . 10.0 113.15 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -123.59 -1.58 8.5 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.936 0.894 . . . . 10.0 113.05 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 65.28 47.13 2.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 10.0 110.129 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.52 151.38 46.08 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 119.628 -0.829 . . . . 10.0 109.741 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 125.75 52.35 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 168.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.0 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.0 mt -107.05 130.49 22.78 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -61.92 114.76 2.43 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.189 1.259 . . . . 10.0 109.081 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.04 60.55 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.948 1.699 . . . . 10.0 109.113 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -71.19 105.31 3.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -52.35 138.57 26.54 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.36 -0.608 . . . . 10.0 109.36 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.451 1.9 . . . . 10.0 111.444 -179.647 . . . . . . . . 0 0 . 1 stop_ save_